Eton Pharmaceuticals Inc
NASDAQ:ETON

Watchlist Manager
Eton Pharmaceuticals Inc Logo
Eton Pharmaceuticals Inc
NASDAQ:ETON
Watchlist
Price: 16.89 USD 0.06% Market Closed
Market Cap: 453m USD

Wall Street
Price Targets

ETON Price Targets Summary
Eton Pharmaceuticals Inc

Wall Street analysts forecast ETON stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ETON is 30.6 USD with a low forecast of 26.26 USD and a high forecast of 36.75 USD.

Lowest
Price Target
26.26 USD
55% Upside
Average
Price Target
30.6 USD
81% Upside
Highest
Price Target
36.75 USD
118% Upside
Eton Pharmaceuticals Inc Competitors:
Price Targets
1093
CSPC Pharmaceutical Group Ltd
33% Upside
4502
Takeda Pharmaceutical Co Ltd
14% Upside
SLGL
Sol Gel Technologies Ltd
21% Upside
GS71
GSK plc
1% Upside
4151
Kyowa Kirin Co Ltd
5% Upside
OGI
OrganiGram Holdings Inc
35% Upside
WEED
Canopy Growth Corp
63% Upside
KILITCH
Kilitch Drugs (India) Ltd
39% Upside

Revenue
Forecast

Revenue Estimate
Eton Pharmaceuticals Inc

The compound annual growth rate of Eton Pharmaceuticals Inc's revenue for the next 3 years is 56%.

N/A
Past Growth
56%
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Eton Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Net Income
Forecast

Net Income Estimate
Eton Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ETON's stock price target?
Price Target
30.6 USD

According to Wall Street analysts, the average 1-year price target for ETON is 30.6 USD with a low forecast of 26.26 USD and a high forecast of 36.75 USD.

What is Eton Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
56%

The compound annual growth rate of Eton Pharmaceuticals Inc's revenue for the next 3 years is 56%.

Back to Top